• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体切除术联合内界膜剥除术治疗牵拉性和非牵拉性糖尿病性黄斑水肿:一项对比研究的长期结果

VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING FOR TRACTIONAL AND NONTRACTIONAL DIABETIC MACULAR EDEMA: Long-term Results of a Comparative Study.

作者信息

Bonnin Sophie, Sandali Otman, Bonnel Sébastien, Monin Claire, El Sanharawi Mohamed

机构信息

*Department of Ophthalmology, Quinze-Vingts National Ophthalmology Hospital, Paris, France; and †National Institute of Health and Medical Research, Cordeliers Research Center, Physiopathology of Ocular Diseases: Therapeutic Innovations, Pierre and Marie Curie University, Paris, France.

出版信息

Retina. 2015 May;35(5):921-8. doi: 10.1097/IAE.0000000000000433.

DOI:10.1097/IAE.0000000000000433
PMID:25545486
Abstract

PURPOSE

To compare the long-term outcomes of vitreomacular surgery in eyes with nontractional diabetic macular edema (DME) with those from eyes with tractional DME.

METHODS

Retrospective comparative study from 55 consecutive patients (73 eyes). Twenty eyes were operated on for tractional DME and 53 eyes for nontractional DME unresponsive to laser photocoagulation or triamcinolone intravitreal injections. The best-corrected visual acuity, the central macular thickness, and the surgical complications were analyzed.

RESULTS

The mean follow-up duration was 5.3 ± 2.4 years for the group with traction and 4.4 ± 1.7 years for the group without traction (P = 0.13). At 3 years, the mean logarithm of the minimum angle of resolution best-corrected visual acuity had improved significantly from 0.78 to 0.58 for the group without traction and from 0.75 to 0.45 for the group with traction (P < 0.001). At the final visit, there was no significant difference between the 2 groups in regard to visual or central macular thickness improvement (P = 0.447 and P = 0.742, respectively). The incidence of surgical complications was not significant between the two groups. The preoperative best-corrected visual acuity was the only predictive factor for the final best-corrected visual acuity.

CONCLUSION

The results of vitrectomy were not different in terms of anatomical and visual outcomes and surgical complications between eyes without tractional DME and eyes with tractional DME.

摘要

目的

比较非牵引性糖尿病性黄斑水肿(DME)眼与牵引性DME眼玻璃体黄斑手术的长期效果。

方法

对55例连续患者(73只眼)进行回顾性比较研究。20只眼因牵引性DME接受手术,53只眼因对激光光凝或曲安奈德玻璃体腔内注射无反应的非牵引性DME接受手术。分析最佳矫正视力、黄斑中心厚度和手术并发症。

结果

牵引组的平均随访时间为5.3±2.4年,非牵引组为4.4±1.7年(P = 0.13)。3年时,非牵引组的最小分辨角对数最佳矫正视力从0.78显著提高到0.58,牵引组从0.75提高到0.45(P < 0.001)。在最后一次随访时,两组在视力或黄斑中心厚度改善方面无显著差异(分别为P = 0.447和P = 0.742)。两组手术并发症的发生率无显著差异。术前最佳矫正视力是最终最佳矫正视力的唯一预测因素。

结论

非牵引性DME眼和牵引性DME眼在玻璃体切除手术的解剖和视觉效果以及手术并发症方面结果无差异。

相似文献

1
VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING FOR TRACTIONAL AND NONTRACTIONAL DIABETIC MACULAR EDEMA: Long-term Results of a Comparative Study.玻璃体切除术联合内界膜剥除术治疗牵拉性和非牵拉性糖尿病性黄斑水肿:一项对比研究的长期结果
Retina. 2015 May;35(5):921-8. doi: 10.1097/IAE.0000000000000433.
2
EFFECT OF INTERNAL LIMITING MEMBRANE PEELING ON LONG-TERM VISUAL OUTCOMES FOR DIABETIC MACULAR EDEMA.内界膜剥除术对糖尿病性黄斑水肿长期视力预后的影响
Retina. 2015 Jul;35(7):1422-8. doi: 10.1097/IAE.0000000000000497.
3
Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.糖尿病性黄斑水肿行玻璃体后皮质切除术联合内界膜剥除术的长期预后
Retina. 2007 Jun;27(5):557-66. doi: 10.1097/01.iae.0000249390.61854.d5.
4
Improvement of visual acuity in eyes with diabetic macular edema after treatment with pars plana vitrectomy.经扁平部玻璃体切割术治疗后,糖尿病性黄斑水肿患者眼睛的视力得到改善。
Ophthalmologica. 2004 Nov-Dec;218(6):378-84. doi: 10.1159/000080940.
5
Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema.玻璃体后皮质切除术联合内界膜剥除术治疗糖尿病性黄斑水肿
Retina. 2008 Mar;28(3):410-9. doi: 10.1097/IAE.0b013e31816102f2.
6
Comparison of anatomical and functional outcomes of vitrectomy with internal limiting membrane peeling in recalcitrant diabetic macular edema with and without traction in Indian patients.比较印度患者伴或不伴牵引的难治性糖尿病性黄斑水肿行玻璃体切割联合内界膜剥除术后的解剖和功能结局。
Indian J Ophthalmol. 2021 Nov;69(11):3297-3301. doi: 10.4103/ijo.IJO_1271_21.
7
Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid.对于无紧张后玻璃体后皮质的难治性糖尿病性黄斑水肿行玻璃体平坦部玻璃体切除术联合内界膜剥除术
Graefes Arch Clin Exp Ophthalmol. 2005 Jan;243(1):20-5. doi: 10.1007/s00417-004-0958-z. Epub 2004 Jul 31.
8
Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema.弥漫性非牵引性糖尿病性黄斑水肿玻璃体切除术的长期随访
Retina. 2009 Apr;29(4):464-72. doi: 10.1097/IAE.0b013e31819c632f.
9
ILM peeling in nontractional diabetic macular edema: review and metanalysis.非牵引性糖尿病性黄斑水肿的内界膜剥除术:综述与荟萃分析
Int Ophthalmol. 2018 Dec;38(6):2709-2714. doi: 10.1007/s10792-017-0761-6. Epub 2017 Oct 31.
10
Macular hypotrophy after internal limiting membrane removal for diabetic macular edema.糖尿病性黄斑水肿行内界膜剥除术后黄斑萎缩
Retina. 2014 Jun;34(6):1182-9. doi: 10.1097/IAE.0000000000000076.

引用本文的文献

1
Intraoperative OCT-Guided Selective Epiretinal Membrane (ERM) Peeling Versus ERM and Internal Limiting Membrane Peeling for Tractional Macular Edema in Diabetic Eyes.术中光学相干断层扫描(OCT)引导下选择性视网膜前膜(ERM)剥除与ERM及内界膜剥除治疗糖尿病性眼牵引性黄斑水肿的比较
Diagnostics (Basel). 2024 Nov 21;14(23):2610. doi: 10.3390/diagnostics14232610.
2
Microinvasive pars plana vitrectomy combined with internal limiting membrane peeling versus anti-VEGF intravitreal injection for treatment-naïve diabetic macular edema (VVV-DME study): study protocol for a randomized controlled trial.微创新庄玻璃体切除术联合内界膜剥除与抗 VEGF 玻璃体注射治疗初治糖尿病黄斑水肿(VVV-DME 研究):一项随机对照试验的研究方案。
Trials. 2023 Oct 24;24(1):685. doi: 10.1186/s13063-023-07735-w.
3
Diabetic retinopathy: emerging concepts of current and potential therapy.糖尿病视网膜病变:当前及潜在治疗的新观念
Naunyn Schmiedebergs Arch Pharmacol. 2023 Dec;396(12):3395-3406. doi: 10.1007/s00210-023-02599-y. Epub 2023 Jul 4.
4
Mid-term safety and effectiveness of macular peeling one month after intravitreal dexamethasone implant for tractional diabetic macular edema.玻璃体内注射地塞米松植入物治疗牵拉性糖尿病性黄斑水肿 1 个月后黄斑剥除的中期安全性和有效性。
Sci Rep. 2023 Apr 12;13(1):5990. doi: 10.1038/s41598-023-32780-5.
5
Role of Vitrectomy in Nontractional Refractory Diabetic Macular Edema.玻璃体切除术在非牵引性难治性糖尿病性黄斑水肿中的作用
J Clin Med. 2023 Mar 15;12(6):2297. doi: 10.3390/jcm12062297.
6
Vitreous inflammatory and angiogenic factors on patients with proliferative diabetic retinopathy or diabetic macular edema: the role of Lipocalin2.玻璃体炎症和血管生成因子在增生性糖尿病视网膜病变或糖尿病性黄斑水肿患者中的作用:脂联素 2 的作用。
BMC Ophthalmol. 2022 Dec 19;22(1):496. doi: 10.1186/s12886-022-02733-z.
7
Change of Optical Coherence Tomography Morphology and Associated Structural Outcome in Diabetic Macular Edema after Ranibizumab Treatment.雷珠单抗治疗后糖尿病性黄斑水肿的光学相干断层扫描形态学变化及相关结构转归
J Pers Med. 2022 Apr 11;12(4):611. doi: 10.3390/jpm12040611.
8
Role of Combined Therapy of Intravitreal Ranibizumab and Dexamethasone in Refractory Diabetic Macular Edema: a Retrospective Study.玻璃体内注射雷珠单抗与地塞米松联合治疗难治性糖尿病性黄斑水肿的作用:一项回顾性研究
Maedica (Bucur). 2021 Dec;16(4):615-619. doi: 10.26574/maedica.2021.16.4.615.
9
Diabetic macular edema treatment guidelines in India: All India Ophthalmological Society Diabetic Retinopathy Task Force and Vitreoretinal Society of India consensus statement.印度糖尿病性黄斑水肿治疗指南:全印度眼科协会糖尿病视网膜病变工作组和印度玻璃体视网膜学会共识声明。
Indian J Ophthalmol. 2021 Nov;69(11):3076-3086. doi: 10.4103/ijo.IJO_1469_21.
10
Vitrectomy for diabetic macular edema and the relevance of external limiting membrane.玻璃体切割术治疗糖尿病性黄斑水肿及外界膜的相关性。
BMC Ophthalmol. 2021 Sep 15;21(1):334. doi: 10.1186/s12886-021-02095-y.